請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35801完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 蘇慧敏(Hui-Min Su) | |
| dc.contributor.author | Chung-Yu Lo | en |
| dc.contributor.author | 駱中郁 | zh_TW |
| dc.date.accessioned | 2021-06-13T07:10:52Z | - |
| dc.date.available | 2006-02-14 | |
| dc.date.copyright | 2005-08-04 | |
| dc.date.issued | 2005 | |
| dc.date.submitted | 2005-07-26 | |
| dc.identifier.citation | (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350, 1047-1059.
行政院衛生署. (2004). Abou-Issa, H. M., Alshafie, G. A., Seibert, K., Koki, A. T., Masferrer, J. L. & Harris, R. E. (2001). Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res 21, 3425-3432. Aylsworth, C. F., Jone, C., Trosko, J. E., Meites, J. & Welsch, C. W. (1984). Promotion of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis by high dietary fat in the rat: possible role of intercellular communication. J Natl Cancer Inst 72, 637-645. Badawi, A. F., El-Sohemy, A., Stephen, L. L., Ghoshal, A. K. & Archer, M. C. (1998). The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands. Carcinogenesis 19, 905-910. Braden, L. M. & Carroll, K. K. (1986). Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 21, 285-288. Brueggemeier, R. W., Richards, J. A. & Petrel, T. A. (2003). Aromatase and cyclooxygenases: enzymes in breast cancer. J Steroid Biochem Mol Biol 86, 501-507. Bunyagidj, C. & McLachlan, J. A. (1988). Catechol estrogen formation in mouse uterus. J Steroid Biochem 31, 795-801. Carmichael, A. R. & Bates, T. (2004). Obesity and breast cancer: a review of the literature. Breast 13, 85-92. Carroll, K. K. (1975). Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Res 35, 3374-3383. Carroll, K. K. (1991). Dietary fats and cancer. Am J Clin Nutr 53, 1064S-1067S. Carroll, K. K., Hopkins, G. J., Kennedy, T. G. & Davidson, M. B. (1981). Essential fatty acids in relation to mammary carcinogenesis. Prog Lipid Res 20, 685-690. Cavalieri, E. L. & Rogan, E. G. (2002). A unified mechanism in the initiation of cancer. Ann N Y Acad Sci 959, 341-354. Cavalieri, E. L., Rogan, E. G. & Chakravarti, D. (2002). Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism. Cell Mol Life Sci 59, 665-681. Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L. & Rogan, E. G. (1997). Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci U S A 94, 10937-10942. Cave, W. T., Jr. (1991a). Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis. Faseb J 5, 2160-2166. Cave, W. T., Jr. (1991b). Omega 3 fatty acid diet effects on tumorigenesis in experimental animals. World Rev Nutr Diet 66, 462-476. Clavel-Chapelon, F. (2002). Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 13, 831-838. Cook, H. W. (1978). In vitro formation of polyunsaturated fatty acids by desaturation in rat brain: some properties of the enzymes in developing brain and comparisons with liver. J Neurochem 30, 1327-1334. Devanesan, P., Todorovic, R., Zhao, J., Gross, M. L., Rogan, E. G. & Cavalieri, E. L. (2001). Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer. Carcinogenesis 22, 489-497. Elce, J. S. (1970). Metabolism of a glutathione conjugate of 2-hydroxyoestradiol by rat liver and kidney preparations in vitro. Biochem J 116, 913-917. el-Ela, S. H., Prasse, K. W., Carroll, R. & Bunce, O. R. (1987). Effects of dietary primrose oil on mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene. Lipids 22, 1041-1044. Fisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R. & et al. (1989). A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320, 479-484. Folch, J., Lees, M. & Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A. & Goldgar, D. E. (1994). Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343, 692-695. Ford, D., Easton, D. F. & Peto, J. (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 57, 1457-1462. Friedman, L. S., Ostermeyer, E. A., Lynch, E. D., Szabo, C. I., Anderson, L. A., Dowd, P., Lee, M. K., Rowell, S. E., Boyd, J. & King, M. C. (1994a). The search for BRCA1. Cancer Res 54, 6374-6382. Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E. & King, M. C. (1994b). Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8, 399-404. Fritsche, K. L. & Johnston, P. V. (1990). Effect of dietary alpha-linolenic acid on growth, metastasis, fatty acid profile and prostaglandin production of two murine mammary adenocarcinomas. J Nutr 120, 1601-1609. Grant, W. B. (2002). An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94, 272-281. Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B. & King, M. C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689. Harris, R. E., Alshafie, G. A., Abou-Issa, H. & Seibert, K. (2000). Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 60, 2101-2103. Harvell, D. M., Strecker, T. E., Xie, B., Pennington, K. L., McComb, R. D. & Shull, J. D. (2002). Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. Carcinogenesis 23, 161-169. Hilakivi-Clarke, L., Cho, E., Cabanes, A., DeAssis, S., Olivo, S., Helferich, W., Lippman, M. E. & Clarke, R. (2002). Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring. Clin Cancer Res 8, 3601-3610. Hilakivi-Clarke, L., Clarke, R., Onojafe, I., Raygada, M., Cho, E. & Lippman, M. (1997). A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci U S A 94, 9372-9377. Hilakivi-Clarke, L., Onojafe, I., Raygada, M., Cho, E., Clarke, R. & Lippman, M. E. (1996). Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy. J Natl Cancer Inst 88, 1821-1827. Hilakivi-Clarke, L., Stoica, A., Raygada, M. & Martin, M. B. (1998). Consumption of a high-fat diet alters estrogen receptor content, protein kinase C activity, and mammary gland morphology in virgin and pregnant mice and female offspring. Cancer Res 58, 654-660. Howe, L. R., Subbaramaiah, K., Brown, A. M. & Dannenberg, A. J. (2001). Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer 8, 97-114. Huang, Z., Hankinson, S. E., Colditz, G. A., Stampfer, M. J., Hunter, D. J., Manson, J. E., Hennekens, C. H., Rosner, B., Speizer, F. E. & Willett, W. C. (1997). Dual effects of weight and weight gain on breast cancer risk. Jama 278, 1407-1411. Hubert, M. F., Laroque, P., Gillet, J. P. & Keenan, K. P. (2000). The effects of diet, ad Libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague-Dawley rats. Toxicol Sci 58, 195-207. Huggins, C., Grand, L. C. & Brillantes, F. P. (1961). Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature 189, 204-207. Hunter, D. J., Spiegelman, D., Adami, H. O., Beeson, L., van den Brandt, P. A., Folsom, A. R., Fraser, G. E., Goldbohm, R. A., Graham, S., Howe, G. R. & et al. (1996). Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med 334, 356-361. Hunter, D. J. & Willett, W. C. (1993). Diet, body size, and breast cancer. Epidemiol Rev 15, 110-132. Ip, C. (1987). Fat and essential fatty acid in mammary carcinogenesis. Am J Clin Nutr 45, 218-224. Ip, C. (1990). Quantitative assessment of fat and calorie as risk factors in mammary carcinogenesis in an experimental model. Prog Clin Biol Res 346, 107-117. Ip, C. & Ip, M. M. (1981). Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat. J Natl Cancer Inst 66, 291-295. Isaacs, J. T. (1986). Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46, 3958-3963. Karmali, R. A., Donner, A., Gobel, S. & Shimamura, T. (1989). Effect of n-3 and n-6 fatty acids on 7,12 dimethylbenz (a) anthracene-induced mammary tumorigenesis. Anticancer Res 9, 1161-1167. Key, T. J. (1995). Hormones and cancer in humans. Mutat Res 333, 59-67. Krinke, G. J. (2000). The Laboratory Rat. 145-176. Lakhani, N. J., Sarkar, M. A., Venitz, J. & Figg, W. D. (2003). 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23, 165-172. Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M. & Wolk, A. (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935-945. Li, C. I., Stanford, J. L. & Daling, J. R. (2000). Anthropometric variables in relation to risk of breast cancer in middle-aged women. Int J Epidemiol 29, 208-213. Liehr, J. G. & Ricci, M. J. (1996). 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci U S A 93, 3294-3296. Markushin, Y., Zhong, W., Cavalieri, E. L., Rogan, E. G., Small, G. J., Yeung, E. S. & Jankowiak, R. (2003). Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem Res Toxicol 16, 1107-1117. Marshall, E. (1993). Epidemiology. Search for a killer: focus shifts from fat to hormones. Science 259, 618-621. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W. & et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71. Mooberry, S. L. (2003). New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent. Curr Opin Oncol 15, 425-430. Morimoto, L. M., White, E., Chen, Z., Chlebowski, R. T., Hays, J., Kuller, L., Lopez, A. M., Manson, J., Margolis, K. L., Muti, P. C., Stefanick, M. L. & McTiernan, A. (2002). Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 13, 741-751. Osborne, C. K., Yochmowitz, M. G., Knight, W. A., 3rd & McGuire, W. L. (1980). The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46, 2884-2888. Parkin, D. M. (2001). Global cancer statistics in the year 2000. Lancet Oncol 2, 533-543. Pisani, P., Parkin, D. M., Bray, F. & Ferlay, J. (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83, 18-29. Reed, M. J. & Purohit, A. (2001). Aromatase regulation and breast cancer. Clin Endocrinol (Oxf) 54, 563-571. Rees, E. D., Shuck, A. E. & Ackermann, H. (1966). Lipid composition of rat mammary carcinomas, mammary glands, and related tissues: endocrine influences. J Lipid Res 7, 396-402. Richards, J. A. & Brueggemeier, R. W. (2003). Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J Clin Endocrinol Metab 88, 2810-2816. Richards, J. A., Petrel, T. A. & Brueggemeier, R. W. (2002). Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells. J Steroid Biochem Mol Biol 80, 203-212. Ringseis, R., Saal, D., Muller, A., Steinhart, H. & Eder, K. (2004). Dietary conjugated linoleic acids lower the triacylglycerol concentration in the milk of lactating rats and impair the growth and increase the mortality of their suckling pups. J Nutr 134, 3327-3334. Russo, I. H. & Russo, J. (1978). Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene. J Natl Cancer Inst 61, 1439-1449. Russo, J., Wilgus, G. & Russo, I. H. (1979). Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 96, 721-736. Sanders, T. A. & Rana, S. K. (1987). Comparison of the metabolism of linoleic and linolenic acids in the fetal rat. Ann Nutr Metab 31, 349-353. Sellers, T. A., Kushi, L. H., Potter, J. D., Kaye, S. A., Nelson, C. L., McGovern, P. G. & Folsom, A. R. (1992). Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 326, 1323-1329. Service, R. F. (1998). New role for estrogen in cancer? Science 279, 1631-1633. Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D. & et al. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15, 342-355. Suchar, L. A., Chang, R. L., Rosen, R. T., Lech, J. & Conney, A. H. (1995). High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. J Pharmacol Exp Ther 272, 197-206. Takata, T., Minoura, T., Takada, H., Sakaguchi, M., Yamamura, M., Hioki, K. & Yamamoto, M. (1990). Specific inhibitory effect of dietary eicosapentaenoic acid on N-nitroso-N-methylurea-induced mammary carcinogenesis in female Sprague-Dawley rats. Carcinogenesis 11, 2015-2019. Todorovic, R., Devanesan, P., Higginbotham, S., Zhao, J., Gross, M. L., Rogan, E. G. & Cavalieri, E. L. (2001). Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. Carcinogenesis 22, 905-911. Totzke, G., Schulze-Osthoff, K. & Janicke, R. U. (2003). Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 22, 8021-8030. Tsukidate, K., Toida, M., Sobue, M., Fukatsu, T., Nagasaka, T., Nakashima, N., Kawaguchi, T. & Takeuchi, J. (1988). Immunohistochemical studies of DMBA-induced rat mammary tumors. Acta Pathol Jpn 38, 129-139. Willett, W. C. (1997). Fat, energy and breast cancer. J Nutr 127, 921S-923S. Willett, W. C. (2001). Diet and breast cancer. J Intern Med 249, 395-411. Xu, X., Duncan, A. M., Merz-Demlow, B. E., Phipps, W. R. & Kurzer, M. S. (1999). Menstrual cycle effects on urinary estrogen metabolites. J Clin Endocrinol Metab 84, 3914-3918. Zhao, Y., Agarwal, V. R., Mendelson, C. R. & Simpson, E. R. (1996). Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137, 5739-5742. Ziegler, R. G., Hoover, R. N., Pike, M. C., Hildesheim, A., Nomura, A. M., West, D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-Ross, P. L., Rosenthal, J. F. & et al. (1993). Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85, 1819-1827. Zock, P. L. (2001). Dietary fats and cancer. Curr Opin Lipidol 12, 5-10. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35801 | - |
| dc.description.abstract | 本論文主要是在探討，何生命期給予實驗動物自製紅花籽油飼料為促進乳癌生成的關鍵時刻，並探討脂肪酸、雌激素與乳癌生成間之可能作用機制。
利用DMBA(7,12-dimethylbenzanthracene)致癌劑來誘發SD雌性大鼠(Sprague-Dawley)乳腺癌，發現： （1） 乳癌潛伏期於給予DMBA後開始計算，在終生組、cox-2抑制劑組、魚油組、胚胎組、成年組中依序為︰49、63、63、70、91天； （2） 乳癌累積發生率則依序為︰51、43、33、69、44%；乳癌累積發生顆數依序為︰1.3、0.6、0.6、1.2、1.1顆。 （3） 每顆乳癌平均體積由大到小依序為︰胚胎組、cox-2抑制劑組、終生組、成年組、魚油組。 （4） 乳腺與乳癌組織中18:2ω6佔總脂肪酸之重量百分比，以胚胎組之比例較高。而各組乳癌組織中之20:4ω6佔總脂肪酸之重量百分比均較其乳腺組織高出近10倍之多。 （5） 比較懷孕時期餵給一般chow diet或實驗飼料，其血清中雌激素的濃度並無明顯差異，但於尿液中之雌激素代謝途徑Hydroxyestrogen和Methylestrogen的比例為懷孕時期餵給實驗飼料之母鼠較高，平均高出約2~4倍之多。 由實驗結果可印證本研究假說： (1) 親代懷孕時期攝取紅花籽油飼料最易促進其子代乳癌之生成。 (2) 飲食中18:2ω6的攝取可經由代謝轉換，增加乳腺組織之18:2ω6與 20:4ω6比例，且會改變雌激素代謝途徑，進而促進乳癌發生；魚油補 充或cox-2抑制劑的添加可減緩乳癌之生成。 本研究結果有助於了解促進乳癌生成之關鍵時期以及作用機制，進而致力於乳癌的預防與治療。 | zh_TW |
| dc.description.abstract | The aim of this study is to evaluate whether dietary safflower oil associated hormone dependent breast cancer originate in utero, and to understand the mechanism of dietary linoleic acid (18:2w6) on promoting breast cancer incidence, studied in DMBA (7, 12-dimethylbenzanthracene) induced Sprague-Dawley rat. Animal was fed with safflower oil experimental diet containing 8.8% of energy from 18:2w6 at a stage of utero, adult, whole life-span (WO), or the experimental diet supplemented with 1500ppm COX-2 inhibitor, celebrex (CE), or 0.1ml/day fish oil (FO).
It was found that: (1) 50% animal vaginal opening at: utero (34-day-old), WO (39), adult (43). (2) Latency to the appearance of a breast cancer at first detection after DMBA administrated: WO (49-day-old), CE (63), FO (63), utero (70), adult (91). (3) % of cumulative breast cancer incidence after DMBA administrated: utero (69%), WO (51%), CE (43%), FO (33%), adult (44%). (4) Breast cancer multiplicity: WO (1.3), utero (1.3), adult (1.1), FO (0.6), CE (0.6). (5) Breast cancer volume (cm3): utero (6.8), CE (6.3), WO (2.5), adult (1.5), FO(1.0). (6) 20:4w6 level is 10 times more in tissue of mammary tumor than mammary gland. (7) The plasma estradiol level at day 18 pregnant animal feeding experimental diet or chow diet was no significant difference. (8) The ratio of 4-hydroxylestradiol to 4-methylestradiol is 2 times more in urine at day 18 pregnant animal feeding experimental diet than that feeding chow diet. We concluded that maternal dietary safflower oil in pregnancy is more potential in causing the breast cancer risk among female offspring than that dietary fed to pups through their whole life. We proposed that the breast cancer incidence was promoted by dietary 18:2w6 via increasing 20:4ω6 level in mammary gland. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T07:10:52Z (GMT). No. of bitstreams: 1 ntu-94-R91441007-1.pdf: 2971267 bytes, checksum: 3f5fbd53dc8ee3f9f4f338c9fa388a53 (MD5) Previous issue date: 2005 | en |
| dc.description.tableofcontents | 致謝………………………………………………………………………I
表次………………………………………………………………………V 圖次……………………………………………………………………VI 中文摘要……………………………………………………………VIII 英文摘要………………………………………………………………IX 壹、 緒論…………………………………………………………1 貳、 文獻回顧 一、 乳癌發生因子………………………………………………2 二、 飲食與乳癌之間的關係……………………………………3 三、 油脂與代謝…………………………………………………4 四、 雌性激素與乳癌之間的關係………………………………7 五、 熱量攝取與乳癌發生率…………………………………10 六、 DMBA誘發SD雌鼠乳癌……………………………………11 七、 實驗目的與假設…………………………………………12 參、 材料與方法 一、 實驗飼料備製……………………………………………13 二、 動物………………………………………………………15 三、 DMBA致癌…………………………………………………16 四、 腫瘤發生檢測……………………………………………17 五、 樣品收集前處理…………………………………………17 六、 分析項目及方法…………………………………………18 七、 統計分析…………………………………………………20 肆、 結果 一、 動物體重差異……………………………………………21 二、 青春期體重及陰道口開啟時間比較……………………22 三、 乳腺癌生長潛伏期以及累積發生率……………………25 四、 乳腺癌發生顆數…………………………………………27 五、 乳腺癌平均直徑與體積…………………………………28 六、 乳腺及乳癌組織脂肪酸檢測……………………………30 七、 雌激素含量分析…………………………………………38 八、 雌性激素代謝產物分析…………………………………39 伍、 討論 一、 實驗動物與飼料…………………………………………45 二、 在雌性動物一生中之不同生命期，餵給實驗飼料與乳癌發 生之關連性………………………………………………49 三、 探討實驗飼料在促進大鼠乳癌生成之作用機制………55 陸、 結論…………………………………………………………57 柒、 參考文獻……………………………………………………58 附錄(一)高18:2ω6飼料對懷孕時期母親雌激素代謝與其子代青春期 的影響………………………………………………………67 附錄(二)中華民國營養學會第三十屆年會壁報……………………69 附錄(三)第一屆白蘭氏健康百萬論文比賽摘要……………………70 附錄(四)中華民國營養學會第三十一屆論文比賽摘要……………71 | |
| dc.language.iso | zh-TW | |
| dc.title | 探討紅花籽油攝取在促進荷爾蒙依賴型乳癌
之作用機制及影響乳癌生成之關鍵時期 | zh_TW |
| dc.title | Studies on the mechanism and critical period of dietary safflower oil on promoting
hormone dependent breast cancer. | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 93-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 黃青真(Ching-jang Huang),呂紹俊(Shao-Chun Lu),胡孟君(Meng-Chun Hu) | |
| dc.subject.keyword | 紅花籽油,荷爾蒙依賴型乳癌,雌激素代謝,脂肪酸組成, | zh_TW |
| dc.subject.keyword | safflower oil,hormone dependent breast cancer,estrogen metabolism,fatty acid composition, | en |
| dc.relation.page | 71 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2005-07-27 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 生理學研究所 | zh_TW |
| 顯示於系所單位： | 生理學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-94-1.pdf 目前未授權公開取用 | 2.9 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。